Drugs News and Research

RSS

Study suggests inexperienced medical staff make fatal medication errors

Are new medical residents a threat to patients? According to Dr. David Phillips and Gwendolyn Barker from the University of California, San Diego in the US, fatal medication errors peak in July in teaching hospitals in particular, which coincides with the yearly influx of new medical residents who are given increased responsibility for patient care.

3 Jun 2010

Nanosponge delivery system more effective at reducing tumor growth than direct injection: Study

When loaded with an anticancer drug, a delivery system based on a novel material called nanosponge is three to five times more effective at reducing tumor growth than direct injection.

3 Jun 2010

Motavizumab should not be licensed for marketing: FDA Antiviral Drugs Advisory Committee

MedImmune today announced that the U.S. Food and Drug Administration's Antiviral Drugs Advisory Committee has voted 14 to 3 to recommend that motavizumab should not be licensed for marketing regarding the prevention of serious respiratory syncytial virus disease in high-risk infants.

3 Jun 2010

ACT Biotech's Telatinib receives orphan drug designation from FDA for treatment of gastric cancer

ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company's highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of gastric cancer.

3 Jun 2010

U.N. Secretary-General calls for African nations to invest 15% of national budgets to fight HIV/AIDS

During a tour of the Joint Clinical Research Centre in Kampala, Uganda, on Monday, U.N. Secretary-General Ban Ki-Moon called for countries in Africa to invest 15 percent of their national budgets in HIV/AIDS programs, the Daily Monitor reports.

3 Jun 2010

Researchers describe chain of molecular events that increase one's risk of skin cancer

As people head to the beach this summer, very few if any, really know how likely they are to develop skin cancer from their outdoor fun. That's about to change, thanks to a new discovery by an international team of scientists that makes it possible for doctors to access people's personal risk for skin cancer.

3 Jun 2010

Regulators miss deadline on medical loss ratios: Other implementation developments continue to emerge

Insurance regulators have missed an early deadline to set specific rules meant to ensure that insurers devote 80 to 85 percent of premium dollars to medical care, the so-called "medical loss ratio."

3 Jun 2010

Insulin pills to manage diabetes are finally moving ahead in clinical trials

After years of research and anticipation, insulin pills that could make it easier for millions of patients worldwide to manage diabetes are finally moving ahead in clinical trials and a step-closer to the medicine cabinet. That's among the topics highlighted in a two-part cover story on drug manufacturing in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

3 Jun 2010

New concept: Hotel 'medical-concierge' program

The Ritz-Carlton's medical-concierge program, now expanded after a trial run to include hospitals and medical facilities throughout the Philadelphia area, aims to provide a pampering bridge between the hospital room and the patient's home. The concierge does not perform medical procedures or administer drugs.

3 Jun 2010

Academic detailing technique may help doctors follow treatment guidelines

Researchers often get frustrated when doctors fail to adopt treatment guidelines backed by the best evidence-based research.

3 Jun 2010

Fraud roundup: LA hospital workers investigated; Guilty pleas in Texas and N.J. cases; Fla. candidate defends his actions

Los Angeles County officials are investigating allegations that Olive View-UCLA Medical Center staff accepted gifts from nursing home employees in exchange for placing Medi-Cal and Medicare patients at their facilities, a possible violation of the county's code of ethics, as well as state and federal anti-kickback laws.

3 Jun 2010

CPAP treatment may be a better option for preterm infants

A national study involving a UT Southwestern Medical Center neonatologist provides new insight into how much oxygen preterm infants should receive as well as the optimal way to deliver it to them.

3 Jun 2010

DBS procedure effective for treating Parkinson's disease

Studies have shown that a "brain pacemaker" called deep brain stimulation (DBS) is an effective treatment for Parkinson's disease.

3 Jun 2010

Novel anti-malarial drug developed from blood thinner by Australian scientists

Malaria caused by a parasite that is borne in female mosquitoes and that spreads in humans through mosquito bites is a major public health problem and it kills more than a million people world wide each year. With the rise of resistance of many of the strains of the malaria parasite to most of the anti-malarial drugs the problem is escalating at an alarming pace.

2 Jun 2010

New oral blood-thinning drugs may have dangerous interactions when taken with prescription drugs : Study

Three new oral blood-thinning drugs nearing approval by the Food and Drug Administration are more convenient than the standard drug Coumadin® because they do not require monthly visits to adjust doses.

2 Jun 2010

Axcan extends use of Medidata Rave as EDC and CDM system

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that Axcan Pharma Inc. has extended its use of Medidata Rave as its electronic data capture and clinical data management system, bringing study build and execution into the organization through Medidata training and mentoring.

2 Jun 2010

Aspirin may not be beneficial for young adults with diabetes

Experts are now recommending that low-dose aspirin therapy to prevent heart attacks be used somewhat more conservatively - that men younger than 50 and women younger than 60, who have diabetes but no other major risk factors, probably not use aspirin.

2 Jun 2010

Asuragen obtains license to integrate BRAF V600E mutation sequence into its molecular diagnostic products

Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.

2 Jun 2010

Constellation Pharmaceuticals raises $22 million in Series B financing round

Constellation Pharmaceuticals, Inc., the leading biopharmaceutical company focused on discovering and developing new drugs targeting epigenetic regulation of the human genome, today announced that it has raised $22 million in a Series B financing round.

2 Jun 2010

Raptor Pharmaceutical acquires exclusive license to intellectual property for Huntington's Disease treatment

Raptor Pharmaceutical Corp., announced that the Company has acquired an exclusive worldwide license to intellectual property related to the potential treatment of Huntington's Disease from the Weizmann Institute of Science in Israel and Niigata University in Japan. In addition, Raptor has added Professor Lawrence Steinman, M.D., an inventor on the Weizmann patent, to its Advisory Board.

2 Jun 2010

Drugs News and Research

Study suggests inexperienced medical staff make fatal medication errors

Nanosponge delivery system more effective at reducing tumor growth than direct injection: Study

Motavizumab should not be licensed for marketing: FDA Antiviral Drugs Advisory Committee

ACT Biotech's Telatinib receives orphan drug designation from FDA for treatment of gastric cancer

U.N. Secretary-General calls for African nations to invest 15% of national budgets to fight HIV/AIDS

Researchers describe chain of molecular events that increase one's risk of skin cancer

Regulators miss deadline on medical loss ratios: Other implementation developments continue to emerge

Insulin pills to manage diabetes are finally moving ahead in clinical trials

New concept: Hotel 'medical-concierge' program

Academic detailing technique may help doctors follow treatment guidelines

Fraud roundup: LA hospital workers investigated; Guilty pleas in Texas and N.J. cases; Fla. candidate defends his actions

CPAP treatment may be a better option for preterm infants

DBS procedure effective for treating Parkinson's disease

Novel anti-malarial drug developed from blood thinner by Australian scientists

New oral blood-thinning drugs may have dangerous interactions when taken with prescription drugs : Study

Axcan extends use of Medidata Rave as EDC and CDM system

Aspirin may not be beneficial for young adults with diabetes

Asuragen obtains license to integrate BRAF V600E mutation sequence into its molecular diagnostic products

Constellation Pharmaceuticals raises $22 million in Series B financing round

Raptor Pharmaceutical acquires exclusive license to intellectual property for Huntington's Disease treatment

Drug Discovery - Second Edition eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News